SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-005482
Filing Date
2019-04-16
Accepted
2019-04-16 16:51:59
Documents
69
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1733059
2 ex10-34.htm EX-10.34 206049
3 ex10-35.htm EX-10.35 98896
4 ex21-1.htm EX-21.1 6791
5 ex23-1.htm EX-23.1 3766
6 ex31-1.htm EX-31.1 16462
7 ex32-1.htm EX-32.1 7499
8 form10-k_001.jpg GRAPHIC 12752
9 form10-k_003.jpg GRAPHIC 24384
  Complete submission text file 0001493152-19-005482.txt   6118663

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE atrx-20181231.xml EX-101.INS 684468
11 XBRL SCHEMA FILE atrx-20181231.xsd EX-101.SCH 59334
12 XBRL CALCULATION FILE atrx-20181231_cal.xml EX-101.CAL 58918
13 XBRL DEFINITION FILE atrx-20181231_def.xml EX-101.DEF 291945
14 XBRL LABEL FILE atrx-20181231_lab.xml EX-101.LAB 441907
15 XBRL PRESENTATION FILE atrx-20181231_pre.xml EX-101.PRE 357806
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-13789 | Film No.: 19751445
SIC: 2834 Pharmaceutical Preparations